{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:47:37Z","timestamp":1791560857818,"version":"4.3.4"},"reference-count":43,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"abstract":"<jats:p>Introduction: metabolic syndrome is a clustering of key cardiovascular risk factors, including abdominal obesity, dyslipidemia, hyperglycemia, and hypertension. Individuals with a combination of metabolic syndrome and type 2 diabetes mellitus (T2DM) have a greater risk of developing microvascular and macrovascular complications, cardiovascular disease, and premature death. This study sought to estimate the prevalence of metabolic syndrome among patients with T2DM in Buea Health District and evaluate its correlation with glycemic control.\n\n \n\nMethods: a hospital based cross-sectional study was carried out in the Buea Health District from February to May 2024. One hundred and thirty-nine patients with T2DM were recruited by a systematic sampling. Sociodemographic, lifestyle, and clinical data were collected. Evaluation of anthropometric variables, fasting plasma glucose, triglycerides, high-density lipoprotein cholesterol, blood pressure, and glycated hemoglobin was performed. Data were analyzed using the Statistical Package for Social Sciences. The level of significance was set at p &lt; 0.05.\n\n \n\nResults: a total of 139 patients with T2DM were recruited in this study with a mean (SD) age of 59.5 \u00b1 10.95 years. The prevalence of metabolic syndrome was 64.00% and 56.80% using the International Diabetes Federation and National Cholesterol Education Program Adult Treatment Panel criteria, respectively. The prevalence was significantly higher in women (56.81%). Central obesity, hyperglycemia, and hypertension were the most common components of metabolic syndrome, and they were more prevalent in female patients. Patients with T2DM who were females, older, who consumed alcohol, did not practice self-glucose monitoring, and had poor glycemic control were more likely to have metabolic syndrome (p &lt; 0.05).\n\n \n\nConclusion: this study observed a high prevalence of metabolic syndrome among patients with T2DM in Buea, Cameroon. Lifestyle changes and good glycemic control are recommended for the prevention of metabolic syndrome in patients with type 2 diabetes mellitus.<\/jats:p>","DOI":"10.11604\/pamj.2026.53.88.46412","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:13:26Z","timestamp":1782486806000},"source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and determinants of metabolic syndrome among patients with type 2 diabetes mellitus in the Buea Health District, South West Region, Cameroon"],"prefix":"10.11604","author":[{"given":"Chu Florence","family":"Mbota","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Science, Faculty of Health Sciences, University of Buea, Buea, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6059-5734","authenticated-orcid":false,"given":"Ebot Walter","family":"Ojong","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, Faculty of Health Sciences, University of Buea, Buea, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achidi Aduni","family":"Ufuan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Science, University of Buea, Buea, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-4273","authenticated-orcid":false,"given":"Ayuk Bertrand","family":"Tambe","sequence":"additional","affiliation":[{"name":"Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"ref0","unstructured":"Nagesh MR, Vijayakumar N, Bhavani K. A review on diabetes mellitus-an annihilatory metabolic disorder. Journal of Pharmaceutical Sciences and Research. 2020 Feb 1;12(2):232-5. Google Scholar"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Gollapalli M, Alansari A, Alkhorasani H, Alsubaii M, Sakloua R, Alzahrani R et al. A novel stacking ensemble for detecting three types of diabetes mellitus using a Saudi Arabian dataset: Pre-diabetes, T1DM, and T2DM. Comput Biol Med. 2022 Aug;147:105757. PubMed | Google Scholar","DOI":"10.1016\/j.compbiomed.2022.105757"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Eizirik DL, Pasquali L, Cnop M. Pancreatic \u0392-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020 Jul;16(7):349-362. PubMed | Google Scholar","DOI":"10.1038\/s41574-020-0355-7"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Artasensi A, Pedretti A, Vistoli G, Fumagalli L. Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs. Molecules. 2020 Apr 23;25(8):1987. PubMed | Google Scholar","DOI":"10.3390\/molecules25081987"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020 Aug 30;21(17):6275. PubMed | Google Scholar","DOI":"10.3390\/ijms21176275"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan;183:109119. PubMed | Google Scholar","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Mbanya JC, Ngogang J, Salah JN, Minkoulou E, Balkau B. Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia. 1997 Jul;40(7):824-9. PubMed | Google Scholar","DOI":"10.1007\/s001250050755"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421. PubMed | Google Scholar","DOI":"10.1161\/circ.106.25.3143"},{"key":"ref8","unstructured":"Zimmet P, Alberti G, Shaw J. A new IDF worldwide defnition of the metabolic syndrome: of the metabolic syndrome: the rationale and the results. Diabetes Voice. 2005;50(3):31-33."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Yadav D, Mahajan S, Subramanian SK, Bisen PS, Chung CH, Prasad GB. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India. Glob J Health Sci. 2013 Sep 17;5(6):142-55. PubMed | Google Scholar","DOI":"10.5539\/gjhs.v5n6p142"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Lone S, Lone K, Khan S, Pampori RA. Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria's given by WHO, NCEPATP III and IDF. J Epidemiol Glob Health. 2017 Dec;7(4):235-239. PubMed | Google Scholar","DOI":"10.1016\/j.jegh.2017.07.004"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ogawa W, Hirota Y, Miyazaki S, Nakamura T, Ogawa Y, Shimomura I et al. Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr J. 2024 Mar 28;71(3):223-231. PubMed | Google Scholar","DOI":"10.1507\/endocrj.EJ23-0593"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Nsiah K, Shang VO, Boateng KA, Mensah FO. Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. Int J Appl Basic Med Res. 2015 May-Aug;5(2):133-8. PubMed | Google Scholar","DOI":"10.4103\/2229-516X.157170"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Anton SD, Moehl K, Donahoo WT, Marosi K, Lee SA, Mainous AG 3rd et al. Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. Obesity (Silver Spring). 2018 Feb;26(2):254-268. PubMed | Google Scholar","DOI":"10.1002\/oby.22065"},{"key":"ref14","unstructured":"Cochran WG. Sampling Techniques, 2nd Ed. New York: John Wiley and Sons, Inc. 1963."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bigna JJ, Nansseu JR, Katte JC, Noubiap JJ. Prevalence of prediabetes and diabetes mellitus among adults residing in Cameroon: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2018 Mar;137:109-118. PubMed | Google Scholar","DOI":"10.1016\/j.diabres.2017.12.005"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Yousefzadeh G, Sayyadi A, Najafipour H, Sabaghnejad V, Pezeshki S. Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study. Endocrinol Diabetes Metab. 2024 Jan;7(1):e468. PubMed | Google Scholar","DOI":"10.1002\/edm2.468"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Semlitsch T, Stigler FL, Jeitler K, Horvath K, Siebenhofer A. Management of overweight and obesity in primary care-A systematic overview of international evidence-based guidelines. Obes Rev. 2019 Sep;20(9):1218-1230. PubMed | Google Scholar","DOI":"10.1111\/obr.12889"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM. The 2017 American College of Cardiology\/American Heart Association Clinical Practice Guideline for High Blood Pressure in Adults. JAMA Cardiol. 2018 Apr 1;3(4):352-353. PubMed | Google Scholar","DOI":"10.1001\/jamacardio.2018.0005"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Moorehead NR, Goodie JL, Krantz DS. Prospective bidirectional relations between depression and metabolic health: 30-year follow-up from the National Heart, Lung, and Blood Institute (NHLBI) Coronary Artery Disease in Young Adults (CARDIA) study. Health Psychol. 2024 Apr;43(4):259-268. PubMed | Google Scholar","DOI":"10.1037\/hea0001339"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract. 1999 Apr;44(1):21-6. PubMed | Google Scholar","DOI":"10.1016\/S0168-8227(99)00008-X"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Hanna FW, Geen J, Issa BG, Tahrani AA, Fryer AA. Limitations of glycosylated haemoglobin (HbA1c) in diabetes screening. Practical Diabetes. 2012 Jan;29(1):29-31. Google Scholar","DOI":"10.1002\/pdi.1653"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Shiferaw WS, Akalu TY, Gedefaw M, Anthony D, Kassie AM, Misganaw Kebede W et al. Metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries: A systematic review and meta-analysis. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1403-1411. PubMed | Google Scholar","DOI":"10.1016\/j.dsx.2020.07.013"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Musilanga N, Nasib H, Jackson G, Shayo F, Nhanga C, Girukwigomba S et al. Exploring the Prevalence and Components of Metabolic Syndrome in Sub-Saharan African Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis. J Obes. 2024 Feb 19;2024:1240457. PubMed | Google Scholar","DOI":"10.1155\/2024\/1240457"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Unadike BC, Akpan NA, Peters EJ, Essien IO, Essien OE. Prevalence of the metabolic syndrome among patients. African Journal of Endocrinology and Metabolism. 2009;8(1):9-11. Google Scholar","DOI":"10.4314\/ajem.v8i1.57575"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Charkos TG, Getnet M. Metabolic syndrome in patients with type 2 diabetes mellitus at Adama Hospital Medical College, Ethiopia: a hospital-based cross-sectional study. Front Clin Diabetes Healthc. 2023 Jun 15;4:1165015. PubMed | Google Scholar","DOI":"10.3389\/fcdhc.2023.1165015"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Osei-Yeboah J, Owiredu WK, Norgbe GK, Yao Lokpo S, Gyamfi J, Alote Allotey E et al. The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana: A Cross-Sectional Study. Int J Chronic Dis. 2017;2017:8765804. PubMed | Google Scholar","DOI":"10.1155\/2017\/8765804"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Kengne AP, Limen SN, Sobngwi E, Djouogo CF, Nouedoui C. Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetol Metab Syndr. 2012 May 31;4(1):22. PubMed | Google Scholar","DOI":"10.1186\/1758-5996-4-22"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Kubota M, Yoneda M, Maeda N, Ohno H, Oki K, Funahashi T et al. Westernization of lifestyle affects quantitative and qualitative changes in adiponectin. Cardiovasc Diabetol. 2017 Jul 6;16(1):83. PubMed | Google Scholar","DOI":"10.1186\/s12933-017-0565-z"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr. 2010 Jan 12; 2:1. PubMed | Google Scholar","DOI":"10.1186\/1758-5996-2-1"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Yoneda M, Kobuke K. A 50-year history of the health impacts of Westernization on the lifestyle of Japanese Americans: A focus on the Hawaii-Los Angeles-Hiroshima Study. J Diabetes Investig. 2020 Nov;11(6):1382-1387. PubMed | Google Scholar","DOI":"10.1111\/jdi.13278"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Cameron AJ, Boyko EJ, Sicree RA, Zimmet PZ, S\u00f6derberg S, Alberti KG et al. Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity (Silver Spring). 2008 Dec;16(12):2707-16. PubMed | Google Scholar","DOI":"10.1038\/oby.2008.412"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Brown LK. A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest. 2002 Sep;122(3):774-8. PubMed | Google Scholar","DOI":"10.1378\/chest.122.3.774"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Shera AS, Jawad F, Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract. 2007 May;76(2):219-22. PubMed | Google Scholar","DOI":"10.1016\/j.diabres.2006.08.011"},{"key":"ref34","unstructured":"Habib SS. Gender differences in lipid and glycemic control in Saudi patients with type 2 diabetes mellitus. Rawal Medical Journal. 2013 Jan 1;38(1):22-5. Google Scholar"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care. 2010 Nov;33(11):2457-61. PubMed | Google Scholar","DOI":"10.2337\/dc10-0942"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Ofori-Asenso R, Agyeman AA, Laar A. Metabolic Syndrome in Apparently \"Healthy\" Ghanaian Adults: A Systematic Review and Meta-Analysis. Int J Chronic Dis. 2017;2017:2562374. PubMed | Google Scholar","DOI":"10.1155\/2017\/2562374"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Chowdhury MZI, Anik AM, Farhana Z, Bristi PD, Abu Al Mamun BM, Uddin MJ et al. Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies. BMC Public Health. 2018 Mar 2;18(1):308. PubMed | Google Scholar","DOI":"10.1186\/s12889-018-5209-z"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Li R, Li W, Lun Z, Zhang H, Sun Z, Kanu JS et al. Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 2016 Apr 1;16:296. PubMed | Google Scholar","DOI":"10.1186\/s12889-016-2870-y"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Jaspers Faijer-Westerink H, Kengne AP, Meeks KAC, Agyemang C. Prevalence of metabolic syndrome in sub-Saharan Africa: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2020 Apr 12;30(4):547-565. PubMed | Google Scholar","DOI":"10.1016\/j.numecd.2019.12.012"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab. 2007 Oct;3(10):696-704. PubMed | Google Scholar","DOI":"10.1038\/ncpendmet0616"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Shita A, Teshome H, Ayalew M, Yesuf W, Getachew D. Metabolic syndrome and its associated factors among type 2 diabetic patients in Mizan-Tepi University Teaching Hospital, Southwest Ethiopia Region. Front Clin Diabetes Healthc. 2023 Sep 13;4:1234674. PubMed | Google Scholar","DOI":"10.3389\/fcdhc.2023.1234674"},{"key":"ref42","unstructured":"Emanuele NV, Swade TF, Emanuele MA. Consequences of alcohol use in diabetics. Alcohol Health Res World. 1998;22(3):211-9. PubMed | Google Scholar"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:14:31Z","timestamp":1782486871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/53\/88\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":43,"URL":"https:\/\/doi.org\/10.11604\/pamj.2026.53.88.46412","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}